Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels

CompletedOBSERVATIONAL

Enrollment

99,999

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

November 15, 2020

Study Completion Date

November 15, 2020

Conditions

Myocardial InfarctionStroke (Including Ischaemic Stroke and Transient Ischaemic Attack)Unstable AnginaAnginaIschaemic Heart Disease

Interventions

DRUG

Acetylsalicylic Acid (Aspirin, BAYE4465)

75-100mg

Trial Locations (2)

Many Locations, Multiple Locations